G01N 33/57505
Of the blood
Official title: of the blood, e.g. leukaemia
G01N33/57505 (Of the blood) appears on 587 US grants and 1,260 published applications in this corpus.
Search patents in G01N- Granted patents
- 587
- Published applications
- 1,260
- Assignees
- 612
- Inventors
- 2,426
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 3 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 4 | 0 |
| 1998 | 6 | 0 |
| 1999 | 3 | 0 |
| 2000 | 6 | 0 |
| 2001 | 2 | 1 |
| 2002 | 2 | 12 |
| 2003 | 8 | 22 |
| 2004 | 8 | 25 |
| 2005 | 4 | 25 |
| 2006 | 7 | 33 |
| 2007 | 3 | 54 |
| 2008 | 17 | 41 |
| 2009 | 14 | 47 |
| 2010 | 24 | 48 |
| 2011 | 20 | 72 |
| 2012 | 17 | 54 |
| 2013 | 29 | 54 |
| 2014 | 43 | 61 |
| 2015 | 29 | 77 |
| 2016 | 31 | 68 |
| 2017 | 37 | 73 |
| 2018 | 34 | 67 |
| 2019 | 42 | 62 |
| 2020 | 31 | 66 |
| 2021 | 30 | 54 |
| 2022 | 31 | 59 |
| 2023 | 28 | 55 |
| 2024 | 22 | 53 |
| 2025 | 22 | 52 |
| 2026 | 23 | 25 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Reagent composition for immunophenotyping of B lymphoblastic leukemia/lymphoma and use thereof8 Sep 2026US 12,730,107 B2
- Cancer diagnosis using Ki-674 Aug 2026US 12,699,095 B2Quest Diagnostics Investments Incorporated
- CD33 antibodies16 Jun 2026US 12,655,216 B2University of Florida Research Foundation, Inc.
- PLK1 target phosphorylation status and treatment of cancer with PLK1 inhibitors16 Jun 2026US 12,655,462 B2Cardiff Oncology, Inc.
- Method for diagnosing human T-cell leukemia virus type 1 (HTLV-1)-related disease16 Jun 2026US 12,656,345 B2NEC Corporation
- Medicament for treating cancer comprising optically active azabicyclo ring derivative27 Aug 2026US 2026/0248787 A9Sumitomo Pharma Co., Ltd.
- Methods of treating disorders using csf1r inhibitors20 Aug 2026US 2026/0240849 A1Deciphera Pharmaceuticals, LLC
- Anti-trem1 antibody agents, compositions, and uses thereof20 Aug 2026US 2026/0242465 A1Celsius Therapeutics, Inc.
- Methods of Treating High Risk Multiple Myeloma20 Aug 2026US 2026/0242503 A1Janssen Biotech, Inc.
- Biomarkers and uses thereof for treatment of cancer with cd19-targeted adoptive cell therapies20 Aug 2026US 2026/0243772 A1Memorial Hospital for Cancer and Allied Diseases
Most cited
By later US patents
- Radioimmunotherapy of lymphoma using anti-CD20178US 5,595,721 ACoulter Pharmaceutical, Inc. · 1997
- Human FGF-21 nucleic acids138US 6,716,626 B1Chiron Corporation · 2004
- Methods and compositions for detecting human tumors119US 4,699,877 AThe Regents of the University of California · 1987
- Modified PSMA ligands and uses related thereto119US 6,875,886 B2Beth Israel Deaconess Medical Center, Inc. · 2005
- Systematic evolution of ligands by exponential enrichment: tissue selex104US 5,712,375 ANeXstar Pharmaceuticals, Inc. · 1998